TELA vs. SMLR, NPCE, ZIMV, NYXH, LUNG, TCMD, NNOX, CVRX, SMTI, and AVR
Should you be buying TELA Bio stock or one of its competitors? The main competitors of TELA Bio include Semler Scientific (SMLR), NeuroPace (NPCE), ZimVie (ZIMV), Nyxoah (NYXH), Pulmonx (LUNG), Tactile Systems Technology (TCMD), Nano-X Imaging (NNOX), CVRx (CVRX), Sanara MedTech (SMTI), and Anteris Technologies Global (AVR). These companies are all part of the "medical equipment" industry.
TELA Bio vs.
TELA Bio (NASDAQ:TELA) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, community ranking, risk and valuation.
Semler Scientific has lower revenue, but higher earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.
TELA Bio currently has a consensus target price of $9.25, suggesting a potential upside of 290.30%. Semler Scientific has a consensus target price of $71.00, suggesting a potential upside of 88.94%. Given TELA Bio's higher probable upside, research analysts plainly believe TELA Bio is more favorable than Semler Scientific.
Semler Scientific has a net margin of 72.65% compared to TELA Bio's net margin of -60.49%. Semler Scientific's return on equity of 50.77% beat TELA Bio's return on equity.
TELA Bio received 57 more outperform votes than Semler Scientific when rated by MarketBeat users. Likewise, 74.68% of users gave TELA Bio an outperform vote while only 66.67% of users gave Semler Scientific an outperform vote.
In the previous week, Semler Scientific had 4 more articles in the media than TELA Bio. MarketBeat recorded 7 mentions for Semler Scientific and 3 mentions for TELA Bio. Semler Scientific's average media sentiment score of 0.68 beat TELA Bio's score of 0.63 indicating that Semler Scientific is being referred to more favorably in the news media.
TELA Bio has a beta of 1, indicating that its share price has a similar volatility profile to the S&P 500.Comparatively, Semler Scientific has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500.
94.3% of TELA Bio shares are held by institutional investors. Comparatively, 49.4% of Semler Scientific shares are held by institutional investors. 6.0% of TELA Bio shares are held by insiders. Comparatively, 30.2% of Semler Scientific shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
Semler Scientific beats TELA Bio on 11 of the 17 factors compared between the two stocks.
Get TELA Bio News Delivered to You Automatically
Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
TELA Bio Competitors List
Related Companies and Tools
This page (NASDAQ:TELA) was last updated on 3/4/2025 by MarketBeat.com Staff
